speb/financial-data huggingface dataset:
ASML.AS cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 171500000.00
ASML.AS cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 1210000000.00
ASML.AS cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -57600000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -22500000.00
ASML.AS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1708400000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -501900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1573600000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -447900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Raw Materials: 5298500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Raw Materials: 5298500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Receivables: 4619300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Receivables: 4619300000.00
ASML.AS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 15409300000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4649500000.00
ASML.AS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1025900000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 255200000.00
ASML.AS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1066700000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1066000000.00
ASML.AS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -5950000000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1700000000.00
ASML.AS income_statement (annual, 2025-12-31) — Research And Development: 4698800000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Research And Development: 1262300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Retained Earnings: 17587300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 17587300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Sale Of Investment: 5300000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 5300000.00
ASML.AS income_statement (annual, 2025-12-31) — Selling General And Administration: 1257800000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 375200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Share Issued: 388147674.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Share Issued: 388147674.00
ASML.AS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 202300000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 55600000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 19612200000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 19612200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 14483500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 14483500000.00
ASML.AS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ASML.AS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ASML.AS income_statement (annual, 2025-12-31) — Tax Provision: 2013400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Tax Provision: 618700000.00
ASML.AS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.18
ASML.AS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
ASML.AS balance_sheet (annual, 2025-12-31) — Taxes Receivable: 276100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 276100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Assets: 50566600000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Assets: 50566600000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Capitalization: 22321200000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 22321200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Debt: 4390900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Debt: 4390900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 19612200000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 19612200000.00
ASML.AS income_statement (annual, 2025-12-31) — Total Expenses: 21365900000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Total Expenses: 6287000000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 30954400000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 30954400000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 19950500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 19950500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6690500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6690500000.00
ASML.AS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 11301400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 3431100000.00
ASML.AS income_statement (annual, 2025-12-31) — Total Other Finance Cost: -104700000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -11200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 486600000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 486600000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 2730009.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 2730009.00
ASML.AS balance_sheet (annual, 2025-12-31) — Treasury Stock: 2252900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 2252900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Work In Process: 4768500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Work In Process: 4768500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Working Capital: 6352200000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Working Capital: 6352200000.00
ASML.AS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1487200000.00
ASML.AS income_statement (quarterly, 2026-03-31) — +Total Revenue: 8766900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4402900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 500000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1322500000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 385400000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Basic EPS: 7.15
ASML.AS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 12916000000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -422300000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 7970400000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 8376300000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -617000000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -2274900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -487600000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2185600000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5158100000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Changes In Cash: -4948100000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 20829500000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 35000000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1000000000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4121900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Current Assets: 27583800000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 20288000000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -42100000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Deferred Tax: -42100000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 259400000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 259400000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 385700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Diluted EPS: 7.15
ASML.AS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2756700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — EBIT: 3157800000.00
ASML.AS income_statement (quarterly, 2026-03-31) — EBITDA: 3157800000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 104600000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -113300000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 2500000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — End Cash Position: 7970400000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -2274900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -2607900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Goodwill: 4588600000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5120700000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 8090700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Gross Profit: 4645000000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Inventory: 11711200000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2705600000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -487600000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1322500000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2258400000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 35000000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 267800000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2705600000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2705600000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -692900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 935900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -965000000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Income: 2756700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2756700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2756700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2756700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2756700000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2756700000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2756700000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -19900000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Interest Income: 40900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1800000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -692900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -692900000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 40900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -63500000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Net PPE: 8090700000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -402400000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 15708800000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 198200000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 416300000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1761900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3821100000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 3585700000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1761900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 235400000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 1725900000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3157800000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Normalized Income: 2756700000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2185600000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -113300000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Operating Income: 3157800000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Operating Revenue: 8766900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 385417665.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1586300000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 20288000000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 532100000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1320900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Other Properties: 8090700000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1174100000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 405900000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Pretax Income: 3198700000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 80200000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -19900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -1800000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -402400000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Receivables: 5910000000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4121900000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 259400000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -692900000.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1000000000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Research And Development: 1184900000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 302300000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Share Issued: 385417665.00
ASML.AS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 31100000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 20829500000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 15708800000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ASML.AS income_statement (quarterly, 2026-03-31) — Tax Provision: 546600000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.17
ASML.AS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 65200000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Total Assets: 48060500000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 23535100000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2705600000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 20829500000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Total Expenses: 5609100000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 27231000000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 20476700000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6943000000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 3157800000.00
ASML.AS income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -40900000.00
ASML.AS balance_sheet (quarterly, 2026-03-31) — Working Capital: 7295800000.00
ASML.TO balance_sheet (annual, 2021-12-31) — Financial Assets: 47300000.00
ASML.TO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -213700000.00
ASML.TO income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 213700000.00
ASML.TO balance_sheet (annual, 2021-12-31) — Non Current Accounts Receivable: 391000000.00
ASML.TO income_statement (annual, 2021-12-31) — Other Income Expense: 213700000.00
ASML.TO income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 213700000.00
ASML.TO cash_flow (annual, 2021-12-31) — Sale Of Business: 329000000.00
ASML.TO income_statement (annual, 2021-12-31) — Special Income Charges: 213700000.00
ASML.TO income_statement (annual, 2021-12-31) — Total Unusual Items: 213700000.00
ASML.TO income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 213700000.00
ASML.TO income_statement (annual, 2022-12-31) — +Operating Expense: 4199400000.00
ASML.TO income_statement (annual, 2022-12-31) — +Total Revenue: 21173400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 2565200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 5323800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3045200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3940800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -4100000.00
ASML.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 39300000.00
ASML.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 18070110393.00
ASML.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.35
ASML.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 6951800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -1319300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 36300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7268300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 7376000000.00
ASML.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2559800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Cash Equivalents: 5744800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 1523500000.00
ASML.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -7138300000.00
ASML.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1028900000.00
ASML.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 8486800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 406200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 439700000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -2080900000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -864300000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 6666300000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Payable: 406200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 845900000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -2125800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 2441200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2338000000.00
ASML.TO cash_flow (annual, 2022-12-31) — Changes In Cash: 319600000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Common Stock: 36300000.00
ASML.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2559800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 8810800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 81800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -4639700000.00
ASML.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 10473300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1875900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Current Assets: 23064900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Current Debt: 746200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 746200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 12481000000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 12481000000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 17983600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -564200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -564200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 71100000.00
ASML.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 583600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 583600000.00
ASML.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 18083741353.00
ASML.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.35
ASML.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 5624200000.00
ASML.TO income_statement (annual, 2022-12-31) — EBIT: 6516900000.00
ASML.TO income_statement (annual, 2022-12-31) — EBITDA: 7100500000.00
ASML.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest Net Of Tax: 138000000.00
ASML.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 15300000.00
ASML.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -3100000.00
ASML.TO cash_flow (annual, 2022-12-31) — End Cash Position: 7268300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Financial Assets: 0.00
ASML.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -7138300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 2303800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 7167500000.00
ASML.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
ASML.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 428300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Goodwill: 4555600000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 5398000000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 5327900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 7182100000.00
ASML.TO income_statement (annual, 2022-12-31) — Gross Profit: 10700100000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 17300000.00
ASML.TO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1734600000.00
ASML.TO income_statement (annual, 2022-12-31) — Interest Expense: 60800000.00
ASML.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 60800000.00
ASML.TO income_statement (annual, 2022-12-31) — Interest Income: 16200000.00
ASML.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 16200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 82200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -466900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Inventory: 7199700000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 13071200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1028900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 923600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 81800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 495600000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 3314000000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Leases: 587700000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 3514200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3514200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 495600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -516200000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 923600000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3279700000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -4557900000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Income: 5624200000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 5624200000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 5624200000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 5624200000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 5624200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 5624200000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 5624200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -37500000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Interest Income: -44600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 530400000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -20600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -20600000.00
ASML.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -44600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -240000000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Net PPE: 4136900000.00
ASML.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1281800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3412800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 454900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 1672800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 5536900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 5269900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 1672800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 267000000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 364400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 652800000.00
ASML.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 7100500000.00
ASML.TO income_statement (annual, 2022-12-31) — Normalized Income: 5624200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 8486800000.00
ASML.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 15300000.00
ASML.TO income_statement (annual, 2022-12-31) — Operating Income: 6500700000.00
ASML.TO income_statement (annual, 2022-12-31) — Operating Revenue: 21173400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 394589411.00
ASML.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 266400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 428300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 842400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 15900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Other Properties: 700000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 1488600000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 107700000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Payables: 2880500000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4756400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1158500000.00
ASML.TO income_statement (annual, 2022-12-31) — Pretax Income: 6456100000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
ASML.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 278500000.00
ASML.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
ASML.TO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -37500000.00
ASML.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -334300000.00
ASML.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1281800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 3198900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Receivables: 7047000000.00
ASML.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 10473300000.00
ASML.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 583600000.00
ASML.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -516200000.00
ASML.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -4639700000.00
ASML.TO income_statement (annual, 2022-12-31) — Research And Development: 3253500000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 9046700000.00
ASML.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
ASML.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 864700000.00
ASML.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 945900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Share Issued: 403138042.00
ASML.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 68900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 8810800000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3412800000.00
ASML.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ASML.TO income_statement (annual, 2022-12-31) — Tax Provision: 969900000.00
ASML.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.15
ASML.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 234600000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Assets: 36300400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 12325000000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Debt: 4260400000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 8810800000.00
ASML.TO income_statement (annual, 2022-12-31) — Total Expenses: 14672700000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 27489600000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 13235500000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 9506000000.00
ASML.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 6500700000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 315300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 8548631.00
ASML.TO balance_sheet (annual, 2022-12-31) — Treasury Stock: 4641300000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Work In Process: 2163900000.00
ASML.TO balance_sheet (annual, 2022-12-31) — Working Capital: 5081300000.00
ASML.TO income_statement (annual, 2023-12-31) — +Operating Expense: 5093800000.00
ASML.TO income_statement (annual, 2023-12-31) — +Total Revenue: 27558500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 2347300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 4334100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3586600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 3998100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ASML.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 37500000.00
ASML.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 17892907902.00
ASML.TO income_statement (annual, 2023-12-31) — Basic EPS: 0.45
ASML.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 7268300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -2196200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 36000000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 7004700000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 7010100000.00
ASML.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -2348300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Cash Equivalents: 4516100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 2488600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -3003900000.00
ASML.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2689300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 5443400000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -261700000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 222000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -1646900000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -344300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -2504000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Payable: -261700000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -39700000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 871300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -3663600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 959900000.00
ASML.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -249800000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Common Stock: 36000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -2348300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 13452400000.00
ASML.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 99400000.00
ASML.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -1000000000.00
ASML.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 13422400000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 2177400000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Current Assets: 24393900000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Current Debt: 100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 11441000000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 11441000000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 16274700000.00
ASML.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -133600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Deferred Tax: -133600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 95200000.00
ASML.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 739800000.00
ASML.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 739800000.00
ASML.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 17906538863.00
ASML.TO income_statement (annual, 2023-12-31) — Diluted EPS: 0.45
ASML.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 7839000000.00
ASML.TO income_statement (annual, 2023-12-31) — EBIT: 9236200000.00
ASML.TO income_statement (annual, 2023-12-31) — EBITDA: 9976000000.00
ASML.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest Net Of Tax: 191300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 4200000.00
ASML.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -13800000.00
ASML.TO cash_flow (annual, 2023-12-31) — End Cash Position: 7004700000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Financial Assets: 11300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -3003900000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 2098500000.00
ASML.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 3247200000.00
ASML.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
ASML.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 345000000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Goodwill: 4588600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 5330300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 4334100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 9386400000.00
ASML.TO income_statement (annual, 2023-12-31) — Gross Profit: 14136100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 19800000.00
ASML.TO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 2568300000.00
ASML.TO income_statement (annual, 2023-12-31) — Interest Expense: 152700000.00
ASML.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 152700000.00
ASML.TO income_statement (annual, 2023-12-31) — Interest Income: 193900000.00
ASML.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 193900000.00
ASML.TO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 137800000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -693200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Inventory: 8850700000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 18084000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2689300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 919600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 99400000.00
ASML.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 997800000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Land And Improvements: 4323400000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Leases: 779100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 4631500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4631500000.00
ASML.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 997800000.00
ASML.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -752800000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 919600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 4283300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -33600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -900600000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Income: 7839000000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 7839000000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 7839000000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 7839000000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 7839000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 7839000000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 7839000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -40600000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Interest Income: 41200000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 102000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 245000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 245000000.00
ASML.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 41200000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -561500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Net PPE: 5799800000.00
ASML.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2155600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 8122100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 60600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 401200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 1872300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 5197700000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 4825500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 1872300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 372200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 929200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 531700000.00
ASML.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 9976000000.00
ASML.TO income_statement (annual, 2023-12-31) — Normalized Income: 7839000000.00
ASML.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 5443400000.00
ASML.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 4200000.00
ASML.TO income_statement (annual, 2023-12-31) — Operating Income: 9042300000.00
ASML.TO income_statement (annual, 2023-12-31) — Operating Revenue: 27558500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 393421721.00
ASML.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 92500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 345000000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 741700000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 13600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Other Properties: 600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 1619300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 5400000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Payables: 2656200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 4833600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1164000000.00
ASML.TO income_statement (annual, 2023-12-31) — Pretax Income: 9083500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
ASML.TO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 485300000.00
ASML.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: -33600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -40600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -23600000.00
ASML.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2155600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 4057300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Receivables: 7256800000.00
ASML.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 13422400000.00
ASML.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 739800000.00
ASML.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -752800000.00
ASML.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1000000000.00
ASML.TO income_statement (annual, 2023-12-31) — Research And Development: 3980600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 12379500000.00
ASML.TO cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
ASML.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 125600000.00
ASML.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 1113200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Share Issued: 399584578.00
ASML.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 134800000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 13452400000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 8122100000.00
ASML.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ASML.TO income_statement (annual, 2023-12-31) — Tax Provision: 1435800000.00
ASML.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.16
ASML.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1303400000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Assets: 39957500000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 18083900000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Debt: 4631600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 13452400000.00
ASML.TO income_statement (annual, 2023-12-31) — Total Expenses: 18516200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 26505100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 15563600000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 10230400000.00
ASML.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 9042300000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 308900000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 6162857.00
ASML.TO balance_sheet (annual, 2023-12-31) — Treasury Stock: 3306200000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Work In Process: 3388100000.00
ASML.TO balance_sheet (annual, 2023-12-31) — Working Capital: 8119200000.00
ASML.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 17865645980.00
ASML.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.12
ASML.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 17883820595.00
ASML.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.12
ASML.TO cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
ASML.TO cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
ASML.TO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -700000.00
ASML.TO cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
ASML.TO cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
ASML.TO cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 203900000.00
ASML.TO income_statement (annual, 2024-12-31) — +Operating Expense: 5469400000.00
ASML.TO income_statement (annual, 2024-12-31) — +Total Revenue: 28262900000.00
ASML.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 3500400000.00
ASML.TO balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 3500400000.00
ASML.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4477500000.00
ASML.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4213900000.00
ASML.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -4213900000.00
ASML.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 4049000000.00
ASML.TO balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 4049000000.00
ASML.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ASML.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ASML.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 35800000.00
ASML.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 17870189634.00